Alerus Financial’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $204K | Sell |
1,206
-147
| -11% | -$25.1K | 0.01% | 227 |
|
|
2025
Q4 | $228K | Hold |
1,353
| – | – | 0.01% | 160 |
|
|
2025
Q3 | $195K | Hold |
1,353
| – | – | 0.01% | 182 |
|
|
2025
Q2 | $171K | Buy |
+1,353
| New | +$166K | 0.01% | 170 |
|
|
2024
Q4 | – | Sell |
-1,405
| Closed | -$205K | – | 161 |
|
|
2024
Q3 | $205K | Buy |
+1,405
| New | +$203K | 0.02% | 151 |
|
|
2023
Q1 | – | Sell |
-1,561
| Closed | -$205K | – | 168 |
|
|
2022
Q4 | $205K | Buy |
+1,561
| New | +$202K | 0.02% | 157 |
|
|
2022
Q3 | – | Sell |
-2,097
| Closed | -$247K | – | 159 |
|
|
2022
Q2 | $247K | Sell |
2,097
-1,622
| -44% | -$193K | 0.02% | 150 |
|
|
2022
Q1 | $485K | Sell |
3,719
-194
| -5% | -$25.3K | 0.04% | 149 |
|
|
2021
Q4 | $597K | Sell |
3,913
-1,372
| -26% | -$212K | 0.05% | 141 |
|
|
2021
Q3 | $854K | Sell |
5,285
-18,462
| -78% | -$3.11M | 0.08% | 139 |
|
|
2021
Q2 | $3.89M | Sell |
23,747
-4,835
| -17% | -$745K | 0.39% | 66 |
|
|
2021
Q1 | $4.3M | Buy |
28,582
+6,414
| +29% | +$1.02M | 0.45% | 60 |
|
|
2020
Q4 | $3.36M | Sell |
22,168
-337
| -1% | -$48.2K | 0.34% | 81 |
|
|
2020
Q3 | $3.05M | Buy |
22,505
+10,140
| +82% | +$1.38M | 0.34% | 75 |
|
|
2020
Q2 | $1.69M | Buy |
12,365
+6,904
| +126% | +$880K | 0.2% | 97 |
|
|
2020
Q1 | $588K | Sell |
5,461
-237
| -4% | -$27.3K | 0.08% | 120 |
|
|
2019
Q4 | $687K | Sell |
5,698
-245
| -4% | -$27.3K | 0.08% | 119 |
|
|
2019
Q3 | $591K | Sell |
5,943
-27,895
| -82% | -$2.92M | 0.08% | 115 |
|
|
2019
Q2 | $3.69M | Sell |
33,838
-8,448
| -20% | -$899K | 0.5% | 57 |
|
|
2019
Q1 | $4.73M | Sell |
42,286
-25,838
| -38% | -$2.83M | 0.66% | 42 |
|
|
2018
Q4 | $6.57M | Sell |
68,124
-369
| -0.5% | -$39.2K | 1.01% | 21 |
|
|
2018
Q3 | $8.35M | Sell |
68,493
-1,262
| -2% | -$149K | 1.14% | 18 |
|
|
2018
Q2 | $7.66M | Sell |
69,755
-889
| -1% | -$95.1K | 1.09% | 20 |
|
|
2018
Q1 | $7.54M | Sell |
70,644
-9,044
| -11% | -$1M | 1.08% | 22 |
|
|
2017
Q4 | $8.51M | Buy |
79,688
+2,039
| +3% | +$218K | 1.21% | 19 |
|
|
2017
Q3 | $8.63M | Buy |
77,649
+132
| +0.2% | +$14.1K | 1.26% | 20 |
|
|
2017
Q2 | $8.01M | Sell |
77,517
-282
| -0.4% | -$27.8K | 1.19% | 21 |
|
|
2017
Q1 | $7.61M | Buy |
77,799
+477
| +0.6% | +$45.7K | 1.17% | 23 |
|
|
2016
Q4 | $6.84M | Buy |
77,322
+2,280
| +3% | +$208K | 1.11% | 26 |
|
|
2016
Q3 | $7.24M | Sell |
75,042
-9,744
| -11% | -$927K | 1.17% | 18 |
|
|
2016
Q2 | $7.27M | Buy |
+84,786
| New | +$7.61M | 1.22% | 20 |
|
Other funds holding IBB
CB
Alerus Financial's IBB Position: Q1 2026 in Review
Alerus Financial reduced its iShares Biotechnology ETF (IBB) stake by 11% in Q1 2026, selling an estimated $25.1K and leaving 1,206 shares worth $204K. The position accounts for 0.01% of the portfolio, ranked #227.
Alerus Financial first reported a position in IBB in Q2 2016 and has held it in 31 quarters since. The position peaked at $8.63M in Q3 2017. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Alerus Financial held 1,206 shares of iShares Biotechnology ETF worth $204K as of Q1 2026.
- Alerus Financial sold 147 iShares Biotechnology ETF shares in Q1 2026, an estimated $25.1K.
- iShares Biotechnology ETF made up 0.01% of Alerus Financial's portfolio in Q1 2026, its #227 holding.
- Alerus Financial first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 31 quarters since.
- Alerus Financial's iShares Biotechnology ETF position peaked at $8.63M in Q3 2017.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Alerus Financial's 13F filing for Q1 2026, filed 12 May 2026.